Dr. Lee Jung-hee Hematology

Consultant - Hematology , Experience:

Book Appointment

About Doctor

Dr. Lee Jung-hee is among the best hematologist in Seoul, South Korea.

Dr. Lee Jung-hee Education
  • Doctor of Medicine : University of Ulsan
  • Master of Medicine : University of Ulsan
  • Bachelor of Medicine : Chung Ang University
Dr. Lee Jung-hee major professional experiences
  • Associate Professor in Hematology, UUCM AMC
  • Assistant Professor in Hematology, UUCM AMC
  • Assistant Professor in Internal Medicine, Chung Ang University Hospital
  • Fellowship in HematoOncology, UUCM AMC
  • Residency in Internal Medicine, UUCM AMC
  • Internship in Chung Ang University Hospital


Asan Medical Centre, Seoul, South Korea


  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma,
  • Leukemia,
  • Blood disease

Procedures Performed

  • Bone marrow stem cell transplant
  • Cell therapies
  • Chemotherapy

Research & Publications

Prognostic impact of lymphocyte subpopulations in peripheral blood after hematopoietic stem cell transplantation for hematologic malignancies.
The detailed kinetics of cytomegalovirus-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data.
A Case of Primary Bone Marrow Diffuse Large B-cell Lymphoma Presenting With Fibrillar Projections and Hemophagocytic Lymphohistiocytosis.
A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma.
Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors.
Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.
Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia.
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy